Circulating TP53 Mutations Are Predictive and Prognostic Biomarkers in Pancreatic Cancer Patients Treated with FOLFIRINOX ChemotherapyF. van der Sijde,M. Besselink,J.W. de Groot, B. Haberkorn,M. Homs, S. Luelmo, L. Mekenkamp, D. Mustafa, J. Wilmink,C. van Eijck,E. VietschPancreatology（2021）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
